ISOGENIS INC has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ARCHEMIX LLC, AGRAWAL SUDHIR and Neurovision Pharma GmbH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | United States | 2 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Xianghua | 10 |
#2 | Qi Yan | 9 |
#3 | Staerz Uwe D | 8 |
#4 | Konigsberg Paula J | 6 |
#5 | Wheeler Janae | 4 |
#6 | Wall Charles | 4 |
#7 | Spiegel Erin K | 4 |
#8 | Maslanik William J | 4 |
#9 | Brennan Miles B | 4 |
#10 | Yan Qi | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010033722A2 | Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof | |
EP1778296A2 | Specific inhibition of autoimmunity and diseases associated with autoantigens | |
WO2004083244A2 | Specific inhibition of allograft rejection |